Acurx Pharmaceuticals Inc (ACXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACXP | AMGN | BMY | VRTX | GILD |
| Company | Acurx Pharmaceuticals Inc | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.8700 | 265.18 | 57.35 | 467.06 | 92.72 |
| High | 0.9000 | 267.19 | 58.54 | 471.05 | 93.50 |
| Low | 0.7200 | 258.68 | 56.77 | 445.87 | 90.59 |
| Last | 0.7200 | 258.78 | 56.84 | 447.50 | 90.69 |
| Change | -0.1436 | -7.17 | -0.81 | -21.74 | -2.11 |
| % Change | -16.63% | -2.70% | -1.41% | -4.63% | -2.27% |
| Volume | 208,700 | 4,093,500 | 14,111,900 | 1,761,000 | 6,616,100 |
| 20-Day Average Volume | 307,115 | 4,655,770 | 9,761,925 | 1,258,310 | 6,464,030 |
| Previous Close | 0.8636 | 265.95 | 57.65 | 469.24 | 92.80 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.0033 | 277.68 | 58.11 | 462.35 | 91.71 |
| 20-Day Raw Stochastic | 0.00% | 2.48% | 31.91% | 7.95% | 42.44% |
| 20-Day Relative Strength | 25.68% | 27.47% | 50.97% | 41.24% | 50.43% |
| Weighted Alpha | -76.23 | -16.63 | +16.55 | +5.39 | +21.78 |
| Today's Opinion | 100% Sell | 88% Sell | 80% Buy | 56% Sell | 88% Buy |
| Previous Opinion | 100% Sell | 88% Sell | 80% Buy | 24% Sell | 100% Buy |
| Last Month's Opinion | 100% Sell | 40% Sell | 100% Buy | 32% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -18.42% since 12/11/24 | -5.35% since 12/11/24 | +0.34% since 12/11/24 | -4.44% since 12/11/24 | -1.83% since 12/11/24 |
| Low | 0.7200 on 12/18/24 | 258.68 on 12/18/24 | 55.04 on 12/13/24 | 445.87 on 12/18/24 | 89.15 on 12/13/24 |
| High | 0.9290 on 12/13/24 | 275.88 on 12/12/24 | 58.54 on 12/18/24 | 474.18 on 12/17/24 | 93.59 on 12/17/24 |
| 1-Month | |||||
| %Chg | -57.65% since 11/18/24 | -7.17% since 11/18/24 | +0.07% since 11/18/24 | -4.18% since 11/18/24 | +2.52% since 11/18/24 |
| Low | 0.7200 on 12/18/24 | 257.80 on 11/26/24 | 55.04 on 12/13/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 |
| High | 1.7300 on 11/20/24 | 297.32 on 11/25/24 | 60.68 on 11/25/24 | 476.46 on 12/10/24 | 94.65 on 12/11/24 |
| 3-Month | |||||
| %Chg | -63.45% since 09/18/24 | -22.27% since 09/18/24 | +14.27% since 09/18/24 | -5.62% since 09/18/24 | +8.11% since 09/18/24 |
| Low | 0.7200 on 12/18/24 | 257.80 on 11/26/24 | 48.94 on 09/19/24 | 445.00 on 11/21/24 | 81.83 on 09/26/24 |
| High | 2.2000 on 10/04/24 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -68.00% since 06/18/24 | -15.43% since 06/18/24 | +39.28% since 06/18/24 | -4.23% since 06/18/24 | +43.61% since 06/18/24 |
| Low | 0.7200 on 12/18/24 | 257.80 on 11/26/24 | 39.35 on 07/05/24 | 445.00 on 11/21/24 | 64.86 on 06/20/24 |
| High | 3.3250 on 07/18/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 12,163 | 139,102,784 | 115,281,584 | 115,244,224 | 113,023,872 |
| Shares Outstanding, K | 16,893 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 0 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -14,580,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -2,820,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | -1.86 | 0.55 | 0.45 | 0.36 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.17 on 11/12/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/13/24 | 02/04/25 | 02/06/25 | 02/03/25 | 02/11/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 12/13/24 |
| Next Ex-Dividends Date | N/A | 02/14/25 | 01/03/25 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.84 | 49.27 | 0.00 | 20.95 |